- Home
- STTK vs FEBO Comparison
STTK vs FEBO Comparison
Compare STTK & FEBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STTK
- FEBO
- Stock Information
- Founded
- STTK 2016
- FEBO 1993
- Country
- STTK United States
- FEBO Hong Kong
- Employees
- STTK N/A
- FEBO N/A
- Industry
- STTK Biotechnology: Pharmaceutical Preparations
- FEBO
- Sector
- STTK Health Care
- FEBO
- Exchange
- STTK Nasdaq
- FEBO Nasdaq
- Market Cap
- STTK 59.7M
- FEBO 66.3M
- IPO Year
- STTK 2020
- FEBO 2023
- Fundamental
- Price
- STTK $1.24
- FEBO $2.42
- Analyst Decision
- STTK Hold
- FEBO
- Analyst Count
- STTK 3
- FEBO 0
- Target Price
- STTK $2.00
- FEBO N/A
- AVG Volume (30 Days)
- STTK 357.1K
- FEBO 67.0K
- Earning Date
- STTK 11-14-2024
- FEBO 11-29-2024
- Dividend Yield
- STTK N/A
- FEBO N/A
- EPS Growth
- STTK N/A
- FEBO N/A
- EPS
- STTK N/A
- FEBO N/A
- Revenue
- STTK $6,435,000.00
- FEBO $16,319,897.00
- Revenue This Year
- STTK $115.09
- FEBO N/A
- Revenue Next Year
- STTK N/A
- FEBO N/A
- P/E Ratio
- STTK N/A
- FEBO N/A
- Revenue Growth
- STTK 382.75
- FEBO 9.01
- 52 Week Low
- STTK $1.07
- FEBO $1.99
- 52 Week High
- STTK $11.76
- FEBO $17.68
- Technical
- Relative Strength Index (RSI)
- STTK 38.29
- FEBO 31.91
- Support Level
- STTK $1.14
- FEBO $2.05
- Resistance Level
- STTK $1.56
- FEBO $3.01
- Average True Range (ATR)
- STTK 0.12
- FEBO 0.44
- MACD
- STTK 0.07
- FEBO -0.02
- Stochastic Oscillator
- STTK 24.42
- FEBO 19.12
About STTK Shattuck Labs Inc.
Shattuck Labs Inc is a clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. Its product candidate, SL-172154, has been rationally designed to simultaneously inhibit the CD47/SIRPa checkpoint interaction to restore an anti-tumor immune response and to activate the CD40 costimulatory receptor to bolster an immune response. Its product candidate, SL-279252, which is being developed in collaboration with Takeda Pharmaceuticals, or Takeda, has been rationally designed to simultaneously inhibit the PD-1/PD-L1 interaction and activate the OX40 receptor.
About FEBO Fenbo Holdings Limited
Fenbo Holdings Ltd is a company engaged in producing premium personal care electric appliances principally electrical hair styling products such as straighteners, curlers, trimmers, etc., and toy products to overseas markets. It manufactures and sells products such as Straightener, Mini Straightener, and Curling Iron.